Normal view
-
Molecular Therapy
-
Discovery of synthetic TBK1 activator inducing type I interferon-mediated antiviral and antitumor immunity
Lee and colleagues identify MFT251 as a synthetic small-molecule TBK1 agonist that directly activates type I interferon signaling. MFT251 induces broad antiviral defenses and reshapes the tumor microenvironment to enhance antitumor immunity, establishing pharmacologic TBK1 activation as a strategy for innate immune modulation in infection and cancer.
-
cs.AI, q-bio.NC updates on arXiv.org
-
Inverting the Shield: Systematically Generating Safety Tests from Policy Specifications
arXiv:2605.24883v1 Announce Type: new Abstract: The widespread integration of Large Language Models (LLMs) necessitates rigorous and systematic safety evaluation. Existing paradigms either rely on constructed benchmarks to assess safety from predefined perspectives, or employ dynamic red-teaming to probe potential vulnerabilities. While effective, these approaches face challenges, as they depend heavily on expert domain knowledge, offer limited systematic guarantees, and are vulnerable to rapid
Inverting the Shield: Systematically Generating Safety Tests from Policy Specifications
-
cs.AI, q-bio.NC updates on arXiv.org
-
Uncertainty Reasoning with Large Language Models for Explainable Disease Diagnosis
arXiv:2605.25566v1 Announce Type: new Abstract: Clinical decision-making requires reasoning over incomplete, imprecise, and linguistically expressed patient narratives. While large language models (LLMs) excel at extracting latent information from natural language, they lack the verifiability and interpretability essential for trustworthy medical AI. We propose a neuro-symbolic reasoning framework that aligns LLMs with formal logic to enable explainable and formally verifiable medical diagnosis
Uncertainty Reasoning with Large Language Models for Explainable Disease Diagnosis
-
MRD
-
Recent advances in biosensing platforms utilizing exosomal biomarker profiling for cancer diagnosis
Biosens Bioelectron. 2026 May 15;309:118809. doi: 10.1016/j.bios.2026.118809. Online ahead of print.ABSTRACTTumor-derived exosomes carry multidimensional molecular cargo, including surface proteins, microRNAs, and lipids that encode tumor identity and disease dynamics. These features support their application as biomarkers for liquid biopsy-based cancer diagnostics. Circulating tumor DNA undergoes rapid nuclease-mediated degradation, whereas exosomes retain stable molecular information that refl
Recent advances in biosensing platforms utilizing exosomal biomarker profiling for cancer diagnosis
Biosens Bioelectron. 2026 May 15;309:118809. doi: 10.1016/j.bios.2026.118809. Online ahead of print.
ABSTRACT
Tumor-derived exosomes carry multidimensional molecular cargo, including surface proteins, microRNAs, and lipids that encode tumor identity and disease dynamics. These features support their application as biomarkers for liquid biopsy-based cancer diagnostics. Circulating tumor DNA undergoes rapid nuclease-mediated degradation, whereas exosomes retain stable molecular information that reflects the proteomic, transcriptomic, and metabolic states of parent tumor cells. However, clinical translation of exosome-based sensing remains limited by variability in isolation, biological heterogeneity, and the analytical difficulty of detecting low-abundance biomarkers in clinical samples. In this review, we examine cancer-specific exosomal signatures across breast, lung, colorectal, and gastric cancers and evaluate biosensing platforms for exosomal biomarker profiling. We integrate engineering principles, clinical performance metrics, and AI-assisted analysis across complementary biosensing modalities to establish a cross-platform analytical framework. We compare optical platforms based on surface plasmon resonance, localized surface plasmon resonance, and surface-enhanced Raman scattering with photoluminescence- and electrochemical-based platforms in terms of sensitivity, clinical compatibility, and translational potential. Furthermore, we examine artificial intelligence (AI)-assisted biosensing frameworks, including classical machine learning classifiers, deep convolutional networks, ensemble models, explainable AI methods, and large language model interfaces. We evaluate how each framework addresses high-dimensional spectral complexity, nonlinear relationships among signals, and inter-patient variability in exosomal data. Finally, we identify remaining challenges, such as the lack of standardized isolation protocols and the absence of large-scale clinical validation. We further highlight minimal residual disease monitoring and early-stage cancer detection as important and underexplored directions for AI-integrated exosomal biosensing in precision oncology.
PMID:42161118 | DOI:10.1016/j.bios.2026.118809
-
cs.AI, q-bio.NC updates on arXiv.org
-
mSFT: Addressing Dataset Mixtures Overfitting Heterogeneously in Multi-task SFT
arXiv:2603.21606v3 Announce Type: replace-cross Abstract: Current language model training commonly applies multi-task Supervised Fine-Tuning (SFT) using a homogeneous compute budget across all sub-datasets. This approach is fundamentally sub-optimal: heterogeneous learning dynamics cause faster-learning tasks to overfit early while slower ones remain under-fitted. To address this, we introduce mSFT, an iterative, overfitting-aware search algorithm for multi-task data mixtures. mSFT trains the m
mSFT: Addressing Dataset Mixtures Overfitting Heterogeneously in Multi-task SFT
-
cs.AI, q-bio.NC updates on arXiv.org
-
LLM-enabled Applications Require System-Level Threat Monitoring
arXiv:2602.19844v1 Announce Type: cross Abstract: LLM-enabled applications are rapidly reshaping the software ecosystem by using large language models as core reasoning components for complex task execution. This paradigm shift, however, introduces fundamentally new reliability challenges and significantly expands the security attack surface, due to the non-deterministic, learning-driven, and difficult-to-verify nature of LLM behavior. In light of these emerging and unavoidable safety challenge
LLM-enabled Applications Require System-Level Threat Monitoring
-
cs.AI, q-bio.NC updates on arXiv.org
-
Mantis: A Versatile Vision-Language-Action Model with Disentangled Visual Foresight
arXiv:2511.16175v2 Announce Type: replace-cross Abstract: Recent advances in Vision-Language-Action (VLA) models demonstrate that visual signals can effectively complement sparse action supervisions. However, letting VLA directly predict high-dimensional visual states can distribute model capacity and incur prohibitive training cost, while compressing visual states into more compact supervisory signals inevitably incurs information bottlenecks. Moreover, existing methods often suffer from poor